ENFLURANE LIQUID

Země: Kanada

Jazyk: angličtina

Zdroj: Health Canada

Koupit nyní

Aktivní složka:

ENFLURANE

Dostupné s:

ABBVIE CORPORATION

ATC kód:

N01AB04

INN (Mezinárodní Name):

ENFLURANE

Dávkování:

99.9%

Léková forma:

LIQUID

Složení:

ENFLURANE 99.9%

Podání:

INHALATION

Jednotky v balení:

250ML

Druh předpisu:

Prescription

Terapeutické oblasti:

INHALATION ANESTHETICS

Přehled produktů:

Active ingredient group (AIG) number: 0109479001; AHFS:

Stav Autorizace:

CANCELLED POST MARKET

Datum autorizace:

2012-11-02

Charakteristika produktu

                                Prescribing Information
ENFLURANE

(enflurane)
Inhalation Anesthetic
AbbVie Corporation
DATE OF PREPARATION:
8401 Trans Canada Highway
November 1, 2012
Saint-Laurent (Qc) Canada H4S lZ1
DATE OF PREVIOUS REVISION:
Control # 158312
DATE OF REVISION:
- 2 -
NAME OF DRUG
ENFLURANE

(enflurane)
THERAPEUTIC CLASSIFICATION
Inhalation Anesthetic
ACTIONS AND CLINICAL PHARMACOLOGY
ENFLURANE

(enflurane),
a
halogenated
methylethyl
ether,
is
an
inhalation
anesthetic.
Induction and recovery from ENFLURANE

anesthesia are rapid. ENFLURANE

does not
appear to stimulate excessive salivation or tracheo-bronchial
secretions, or affect bronchomotor
tone. Pharyngeal and laryngeal reflexes are readily obtunded. The
level of anesthesia can be
changed rapidly by changing the inspired ENFLURANE

concentration. This property would be
predicted based upon its Oswald partition coefficients.
ENFLURANE

reduces ventilation as depth of anesthesia increases. This is a result
of a
decrease in tidal volume with rate of respiration remaining
essentially constant. ENFLURANE

provokes a sigh response reminiscent of diethyl ether.
There is a decrease in blood pressure with induction of anesthesia,
followed by a return to near
normal with surgical stimulation. A slight fall in cardiac output,
stroke volume, and peripheral
resistance, and an increase in central venous pressure may occur.
Progressive increases in
depth of anesthesia produce corresponding increases in hypotension.
Electrocardiographic
monitoring and recording indicate that the cardiac rhythm remains
remarkably stable. Elevation
of carbon dioxide level in arterial blood does not alter cardiac
rhythm.
ENFLURANE

has been shown to sensitize the myocardial conduction system to
epinephrine,
and serious arrhythmias including ventricular fibrillation have
occurred in dogs.
However, studies in human subjects indicate that there is a certain
margin of safety in the
administration
of
epinephrine-containing
solutions
during
ENFLURANE

anesthesia.
ENFLURANE

anesthes
                                
                                Přečtěte si celý dokument
                                
                            

Vyhledávejte upozornění související s tímto produktem

Zobrazit historii dokumentů